Hong Kong biopharmaceutical stocks fell collectively, with the Hang Seng Healthcare Index falling 6%.

2025-09-11 09:38:51

Hong Kong-listed biopharmaceutical stocks fell collectively, with the Hang Seng Healthcare Index's decline widening to 6%. China Biologic Products and Shijiazhuang Pharmaceutical Group fell more than 10%, Fosun Pharma fell more than 7%, and WuXi Biologics and WuXi AppTec both fell more than 5%.

WuXi Biologics WuXi AppTec

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Musk: XAI will certainly raise funds in the next few months, but not now
                            2025-09-20

                                    Nvidia (NVDA.O) fell further, dropping nearly 3%.
                            2025-09-17

                                    SoftBank and OpenAI's AI joint venture in Japan is severely delayed, with an update now expected in November.
                            2025-09-18

                                    HGTECH's 3.2T NPO products are used by leading industry customers
                            2025-09-24

                                    Alipay's two operating entities have completed the name change
                            2025-09-19